Collegium Pharmaceutical (COLL) Intangibles (2018 - 2026)
Collegium Pharmaceutical has reported Intangibles over the past 6 years, most recently at $669.5 million for Q4 2025.
- For Q4 2025, Intangibles fell 24.89% year-over-year to $669.5 million; the TTM value through Dec 2025 reached $669.5 million, down 24.89%, while the annual FY2025 figure was $669.5 million, 24.89% down from the prior year.
- Intangibles for Q4 2025 was $669.5 million at Collegium Pharmaceutical, down from $725.0 million in the prior quarter.
- Over five years, Intangibles peaked at $956.2 million in Q3 2022 and troughed at $268.7 million in Q4 2021.
- A 5-year average of $651.9 million and a median of $669.5 million in 2025 define the central range for Intangibles.
- Biggest five-year swings in Intangibles: crashed 62.92% in 2024 and later soared 121.3% in 2025.
- Year by year, Intangibles stood at $268.7 million in 2021, then skyrocketed by 111.17% to $567.5 million in 2022, then fell by 25.69% to $421.7 million in 2023, then skyrocketed by 111.38% to $891.4 million in 2024, then fell by 24.89% to $669.5 million in 2025.
- Business Quant data shows Intangibles for COLL at $669.5 million in Q4 2025, $725.0 million in Q3 2025, and $780.5 million in Q2 2025.